Back to companies

Myovant Sciences Ltd: Executives

The following section provides information on Myovant Sciences Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Myovant Sciences Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Myrtle Potter

Chairman Executive Board Since: 2018 Age: 62

David Marek

Chief Executive Officer; Director Executive Board Since: 2021 Age: 56

Matthew Lang

Chief Legal Officer; Chief Administrative Officer; General Counsel; Secretary Senior Management Since: 2017 Age: 45

Juan Camilo Arjona Ferreira

Chief Medical Officer Senior Management Since: 2017 Age: 51

Jeff Nornhold

Senior Vice President - Pharmaceutical Operations and Development Senior Management
Gain a 360-degree view of Myovant Sciences Ltd and make more informed decisions for your business Gain a 360-degree view of Myovant Sciences Ltd and make more informed decisions for your business Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code